Numedico partnership ventures into space to explore novel drug delivery
In keeping with its mission to search beyond what is available today and to strive towards what is possible tomorrow, Numedico Science Pty Ltd, a subsidiary of Numedico Technologies Pty Ltd, has committed to a collaborative partnership with space medtech start-up ResearchSat to explore and expand the development of novel drug delivery methods and therapeutics.
As a global participant in the drug delivery market with safety and sustainability at its core, Numedico is focused on exploring the possibilities for alternative drug delivery methods with ResearchSat, engaging space satellite technology in this research pursuit.
In this collaboration ResearchSat will be developing “Double Emulsion Microfluidic Chip” which generates fluid droplets – one droplet inside another droplet. One of main challenges they’ll be solving is to optimise the chip for macro droplet size and enable it to operate in space environoment. This technology helps to encapsulate drugs in desired quality and quantities. ResearchSat will concurrently be developing an advanced Random Positioning Machine to simulate microgravity effects on microbes and fluids.
As background, a space satellite provides a unique environment with extreme environmental variables enabling the acceleration of life-science research. This environment is a catalyst to fast track experiments to develop, refine, and then apply, alternative ways to administer medicine while reducing industry risks. This technology is set to improve efficiency in how drugs are delivered and digested as well as reduce painful delivery methods. The objective is to transform the lives and health of millions of people who administer medication everyday including diabetics and people who suffer blood pressure.
Founder and CEO Neville Calvert of Numedico said of the venture:
‘Space is the most suitable frontier available to understand how we can reduce risks, increase efficiency, and create better ways to deliver medicine into the human biology. As a company that believes in providing the best possible solutions to the challenges our industry faces, this partnership fills me with excitement and anticipation for what is possible.’
ResearchSat, which specialises in medical space research and drug delivery design, is thrilled to work with an Australian company to bring this research and technology to life.
Founder and CEO ReviTeja Duggineri commented:
‘Developing novel thearpeutics in space is not only intellectually stimulating but feasible and profitable as space provides a completely unique and favourable environment that cannot be replicated on earth. In space we can push the boundaries of what is possible. It is the way of the future and those that invest in this vision will lead the way in medtech.
Not one to play catch up, Numedico remains committed to its stakeholders and continues to challenge the status quo and to always be better today than yesterday.
Watch this space!
About ResearchSat – ResearchSat provides end-to-end services that enable space science research in the form of satelite platforms to run experiements in space. Facilitating drug design and development for pharamceutical companies as well as providing opportunities to academic researchers intersted in space biology research.Related news
-
The European Association for the Study of Diabetes celebrates in IFEMA MADRID its 60th Annual Meeting
The annual meeting of the European Association for the Study of Diabetes expects to maintain for its 60th edition the participation level of previous years, in which around 15,000 diabetologists and diabetes experts from 130 countries attended. The scientific programme will feature more than 1,200 sessions on the latest results in diabetes research by leading experts in the field. The congress will also include an hybrid component as has been customary since its 2018 edition. The Association takes advantage of...
-
Creative Enzymes Upgrades Multiple Diagnostic Enzyme Products for Clinical and Diagnostic Research
Creative Enzymes, the world’s leading diagnostic enzyme production company, has been committed to providing customers with various enzyme products and services for medical and research diagnosis. Relying on its professional team and the most advanced technology, as well as high-quality products and services, it has gained solid reputation. Recently, Creative Enzymes has announced multiple diagnostic enzyme products for diagnostics use. Creative Enzymes’s product line of diagnostic enzyme covers...
-
Notitia Biotechnologies company announces expansion of study population for Covid-19 phase 2 study (COVGUT20) for NBT-NM108
After months of preparation, Notitia Biotechnologies Company (Notitia) announced that its COVID-19 Phase 2 study (COVGUT20) for NBT-NM108 has been given support by the Food and Drug Administration (FDA) to expand its study population to all symptomatic COVID-19 patients."Previously, our trial focused on COVID-19 patients with type 2 diabetes and prediabetes. Now with this timely expansion to our study population, we can help more people and test NBT- NM108’s efficacy not just for diabetic patients, but for...
-
Hextransforma Healthcare National Walking Month
May is National Walking Month and we are encouraging all our employees to lace up their shoes, enjoy some: fresh air and fundraise for Diabetes UK. Asa pioneer in Quality of Movement research, we want to highlight the importance of walking in maintaininga good qualityof life and are pledging to walk 3 million steps in 31 days to raise £300 for Diabetes UK, our charity partner. Most people with diabetescan safely get about,:some of them are even athletes, but there are myriad of ways in which having...
-
India’s HealthPlix raises $13.5 million to help doctors treat patients more efficiently
There are fewer than 300,000 doctors in India actively practicing medicine. They serve hundreds of millions of patients who suffer from chronic illness in the world’s second-most populous nation. A doctor only has a few minutes to spend on a patient, remember the past diagnosis by glancing at their record and formulate a plan of management. HealthPlix, a Bangalore-based startup, believes it can help doctors serve these patients more efficiently with the limited time they have. The startup has developed a...
Customer comments
No comments were found for Numedico partnership ventures into space to explore novel drug delivery. Be the first to comment!